183P COMMANDER-001: Initial safety data from a phase I/II dose escalation/expansion study of SQZ-eAPC-HPV, a cell-based mRNA therapeutic cancer vaccine for HPV16+ solid tumors. (December 2022) - Moser, J.; Pelster, M.; Jimeno, A.; Park, J.C.; Iams, W.T.; Wise-Draper, T.; Jennings; Miselis, N.R.; Ji, R.R.; Loughhead, S.M.; Zwirtes, R.; Warren, M.; et al.